» Articles » PMID: 23843863

Attenuation of Proinflammatory Responses by S-[6]-Gingerol Via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells

Overview
Date 2013 Jul 12
PMID 23843863
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction. Hepatic inflammation underlies the pathogenesis of chronic diseases such as insulin resistance and type 2 diabetes mellitus. S-[6]-Gingerol has been shown to have anti-inflammatory properties. Important inflammatory mediators of interleukins include nuclear factor κ B (NF κ B) and cyclooxygenase 2 (COX2). We now explore the mechanism of anti-inflammatory effects of S-[6]-gingerol in liver cells. Methods. HuH7 cells were stimulated with IL1β to establish an in vitro hepatic inflammatory model. Results. S-[6]-Gingerol attenuated IL1β-induced inflammation and oxidative stress in HuH7 cells, as evidenced by decreasing mRNA levels of inflammatory factor IL6, IL8, and SAA1, suppression of ROS generation, and increasing mRNA levels of DHCR24. In addition, S-[6]-gingerol reduced IL1β-induced COX2 upregulation as well as NF κ B activity. Similar to the protective effects of S-[6]-gingerol, both NS-398 (a selective COX2 inhibitor) and PDTC (a selective NF κ B inhibitor) suppressed mRNA levels of IL6, IL8, and SAA1. Importantly, PDTC attenuated IL1β-induced overexpression of COX2. Of particular note, the protective effect of S-[6]-gingerol against the IL1β-induced inflammatory response was similar to that of BHT, an ROS scavenger. Conclusions. The findings of this study demonstrate that S-[6]-gingerol protects HuH7 cells against IL1β-induced inflammatory insults through inhibition of the ROS/NF κ B/COX2 pathway.

Citing Articles

Natural compounds proposed for the management of non-alcoholic fatty liver disease.

Merenda T, Juszczak F, Ferier E, Duez P, Patris S, Decleves A Nat Prod Bioprospect. 2024; 14(1):24.

PMID: 38556609 PMC: 10982245. DOI: 10.1007/s13659-024-00445-z.


Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.

Sahoo D, Heilmann R, Paital B, Patel A, Yadav V, Wong D Front Endocrinol (Lausanne). 2023; 14:1217165.

PMID: 37701897 PMC: 10493311. DOI: 10.3389/fendo.2023.1217165.


Over the Counter Supplements for Memory: A Review of Available Evidence.

Hersant H, He S, Maliha P, Grossberg G CNS Drugs. 2023; 37(9):797-817.

PMID: 37603263 DOI: 10.1007/s40263-023-01031-6.


Anti-Inflammatory Study and Phytochemical Characterization of Roscoe and L. Juices and Their Formulation.

Bekkouch O, Zengin G, Harnafi M, Touiss I, Khoulati A, Saalaoui E ACS Omega. 2023; 8(30):26715-26724.

PMID: 37546676 PMC: 10398691. DOI: 10.1021/acsomega.2c04263.


Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations.

Akter R, Rahman M, Ahmed Z, Afrose A Heliyon. 2023; 9(6):e17478.

PMID: 37366526 PMC: 10284624. DOI: 10.1016/j.heliyon.2023.e17478.


References
1.
Bustin S . Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000; 25(2):169-93. DOI: 10.1677/jme.0.0250169. View

2.
Afzal M, Menon M, Pesek J, Dhami M . Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact. 2002; 18(3-4):159-90. DOI: 10.1515/dmdi.2001.18.3-4.159. View

3.
Li Y, Tran V, Duke C, Roufogalis B . Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Med. 2012; 78(14):1549-55. DOI: 10.1055/s-0032-1315041. View

4.
Lee C, Park G, Kim C, Jang J . [6]-Gingerol attenuates β-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system. Food Chem Toxicol. 2011; 49(6):1261-9. DOI: 10.1016/j.fct.2011.03.005. View

5.
El-Tayeh S, Hussein T, El-Houseini M, Amer M, El-Sherbini M, Elshemey W . Serological biomarkers of hepatocellular carcinoma in Egyptian patients. Dis Markers. 2012; 32(4):255-63. PMC: 3826907. DOI: 10.3233/DMA-2011-0883. View